Arabic Arabic English English French French German German
dark

Nirogy Therapeutics Appoints Simon Pedder, Ph.D., as Chief Executive Officer

Nirogy Therapeutics today announced that it has appointed life science veteran Simon Pedder, Ph.D., as Chief Executive Officer (CEO) and to the Company’s Board of Directors. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Conference Call on Report on Operations 2021

Next Post

Perceval: CORCYM Announces the First Patient Implanted in China

Related Posts
Total
0
Share